MENU
ALLK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Allakos (ALLK) Ownership - Who owns Allakos?
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
825 Industrial Road
Phone
+1 650 597-5002
Employees
131
Web
https://www.allakos.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
19.57M
P/E Ratio
N/A
Total Cash
80.82M
Projected Growth
N/A
Total Debt
4.16M
Revenue
N/A
Risk (Beta)
-0.09
Dividend Yield
N/A
Total Cash/Share
0.90
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ALLK
Capitalization
19.6M
P/E Ratio
N/A
Risk (Beta)
-0.09
Dividend Yield
N/A
Total Cash
80.8M
Total Cash/Share
0.90
Total Debt
4.16M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
78.8M
P/B Ratio
0.25
Cash Flow
N/A
Earnings
-1.3
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
90K
Current Ratio
4.81
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-111.04M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-68.09
Shares Held By Institutions
87.5M
Shares Outstanding - Current
90.2M
Total Liabilities
17.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-82.066
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of antibody therapeutics for allergic and inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
825 Industrial Road
Phone
+1 650 597-5002
Employees
131
Web
https://www.allakos.com